Breast Cancer Research Trust

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 10, 2010	Pathway Therapeutics	$4.5M Series A Extension	CM Capital, GBS Venture Partners	New Zealand Growth Capital Partners, Trans Tasman Commercialisation Fund

Total Raised

N/A

Valuation

N/A